Thirty Madison Stock
Thirty Madison is a patient-first health company bringing specialized care and treatment to people with chronic conditions.
Sign up for SecondMarket™ to view the market and buy or sell Thirty Madison Stock
Buy + SellThirty Madison Funding
Sign up to gain insights into Thirty Madison funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
May 18, 2021 | Series C | 141.00M | ||
Aug 14, 2020 | Series B | 8.85M | ||
Aug 14, 2020 | Series B | 4.99M | ||
Aug 14, 2020 | Series B | 8.16M | ||
Mar 17, 2020 | Series B | 25.00M | ||
Aug 07, 2018 | Series A | 15.25M | ||
Nov 14, 2017 | Seed | 5.00M | ||
May 05, 2017 | Seed | 2.75M |
See Thirty Madison Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Thirty Madison Stock Valuation + Share Prices
View real-time Tape D™ data on Thirty Madison stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedThirty Madison Management Team
Co-Founder, CEO, Director
Steven Gutentag
Director
Randy Scott
Director
Regina Benjamin
Co-Founder, COO, Director
Demetri Karagas
President
Michelle Carnahan
Director
Andrew Weissman
Chief Business Officer
Caroline Hofmann
Chief Medical Officer
Neil Parikh
Chief Technology Officer
Gil Shklarski
Chief People Officer
Chelsea Trombino
Director
Amy Schulman
Chief Financial Officer
Quan Zhang
Director
Jason Stoffer
Thirty Madison Major Investors
Maveron LLC
Northzone Ventures AS
Greycroft Partners LLC
Steadfast Capital
First Round Capital
Two River
HealthQuest Capital
Mousse Partners, Ltd.
Bracket Capital
Polaris Partners
Johnson & Johnson Development Corp (JJDC)